what is the optimal value for the phred score for rna seq data?
Unconfigured Ad
Collapse
X
-
-
It's probably good you're not doing too much on DE/transcript reconstruction as I would have said the read numbers were a little low for anything other than gene level expression testing.Originally posted by arcolombo698 View PostThank you very much for your response
It is RNA-seq experiment.
As already pointed out, you should be fine to do variant calling from the expressed genes, where there is sufficient depth - but you will want to put some kind of depth threshold for the variant calling (also there will be instances of allele specific expression and presumably RNA editing in the data). With different numbers of reads per sample, obviously some samples will have better coverage than others. For differential expression studies this is not so much of an issue when the data is normalised to the number of mapped reads anyway.Last edited by Bukowski; 12-25-2013, 06:58 AM.
Comment
-
thank you for the response
are there resources recommended that gives insight about understanding sufficient depth of reads for variant calling and other common problems? it seems sufficient to have read lengths of 13M.. i have a sample read with 7M , this seems also low.
these samples have all passed QC with no duplicated sequences (all the repeated sequences have been trimmed out...dont want duplicated sequences)
would appreciate resources on how to properly process VCF , and also how to analyze the VCF results, error checking etc...
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
25 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
20 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment